Scarica l'app Stockscreener
239.34
0.11%
-0.44
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$239.78
Aprire:
$239.995
Volume 24 ore:
42.78M
Relative Volume:
0.81
Capitalizzazione di mercato:
$3.55T
Reddito:
$408.63B
Utile/perdita netta:
$99.28B
Rapporto P/E:
36.32
EPS:
6.59
Flusso di cassa netto:
$96.18B
1 W Prestazione:
+3.17%
1M Prestazione:
+18.03%
6M Prestazione:
+1.60%
1 anno Prestazione:
+7.70%
Intervallo 1D:
$238.49
$241.32
Intervallo di 1 settimana:
$226.97
$241.32
Portata 52W:
$169.21
$260.10
Apple Inc Stock (AAPL) Company Profile
Nome
Apple Inc
Settore
Industria
Telefono
(408) 996-1010
Indirizzo
ONE APPLE PARK WAY, CUPERTINO, CA
Confronta AAPL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AAPL
Apple Inc
|
239.20 | 3.56T | 408.63B | 99.28B | 96.18B | 6.59 |
|
SONY
Sony Group Corporation Adr
|
27.52 | 166.42B | 83.81B | 7.93B | 18.33B | 1.2696 |
|
LPL
Lg Display Co Ltd Adr
|
4.46 | 4.48B | 19.69B | -1.47B | -1.21B | -1.481 |
|
SONO
Sonos Inc
|
14.66 | 1.74B | 1.41B | -76.38M | 57.03M | -0.65 |
|
ZEPP
Zepp Health Corporation Adr
|
49.47 | 726.31M | 353.29M | -30.72M | 0 | -0.5039 |
Apple Inc Stock (AAPL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-04 | Aggiornamento | MoffettNathanson | Sell → Neutral |
| 2025-08-21 | Reiterato | Loop Capital | Hold |
| 2025-08-07 | Reiterato | BofA Securities | Buy |
| 2025-08-01 | Reiterato | Barclays | Underweight |
| 2025-08-01 | Reiterato | BofA Securities | Buy |
| 2025-08-01 | Reiterato | Citigroup | Buy |
| 2025-08-01 | Reiterato | JP Morgan | Overweight |
| 2025-08-01 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-08-01 | Reiterato | Morgan Stanley | Overweight |
| 2025-08-01 | Reiterato | Raymond James | Outperform |
| 2025-08-01 | Reiterato | UBS | Neutral |
| 2025-07-02 | Aggiornamento | Jefferies | Underperform → Hold |
| 2025-06-26 | Reiterato | JP Morgan | Overweight |
| 2025-06-04 | Downgrade | Needham | Buy → Hold |
| 2025-05-02 | Downgrade | Jefferies | Hold → Underperform |
| 2025-05-02 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-05-02 | Downgrade | Rosenblatt | Buy → Neutral |
| 2025-05-02 | Reiterato | TD Cowen | Buy |
| 2025-04-30 | Reiterato | Barclays | Underweight |
| 2025-04-30 | Reiterato | Loop Capital | Hold |
| 2025-04-29 | Reiterato | Morgan Stanley | Overweight |
| 2025-04-28 | Reiterato | Morgan Stanley | Overweight |
| 2025-04-24 | Reiterato | BofA Securities | Buy |
| 2025-04-22 | Ripresa | China Renaissance | Buy |
| 2025-04-14 | Reiterato | JP Morgan | Overweight |
| 2025-04-14 | Aggiornamento | KeyBanc Capital Markets | Underweight → Sector Weight |
| 2025-04-09 | Aggiornamento | Jefferies | Underperform → Hold |
| 2025-04-08 | Reiterato | KeyBanc Capital Markets | Underweight |
| 2025-04-08 | Reiterato | Morgan Stanley | Overweight |
| 2025-03-18 | Reiterato | Evercore ISI | Outperform |
| 2025-01-31 | Reiterato | KeyBanc Capital Markets | Underweight |
| 2025-01-29 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-01-28 | Reiterato | TD Cowen | Buy |
| 2025-01-24 | Reiterato | BofA Securities | Buy |
| 2025-01-23 | Reiterato | Goldman | Buy |
| 2025-01-21 | Downgrade | Jefferies | Hold → Underperform |
| 2025-01-21 | Downgrade | Loop Capital | Buy → Hold |
| 2025-01-07 | Downgrade | MoffettNathanson | Neutral → Sell |
| 2025-01-03 | Reiterato | Bernstein | Outperform |
| 2024-12-26 | Reiterato | Wedbush | Outperform |
| 2024-12-02 | Reiterato | UBS | Neutral |
| 2024-11-19 | Reiterato | MoffettNathanson | Neutral |
| 2024-11-04 | Reiterato | Loop Capital | Buy |
| 2024-11-01 | Reiterato | Maxim Group | Hold |
| 2024-10-25 | Downgrade | KeyBanc Capital Markets | Sector Weight → Underweight |
| 2024-10-07 | Downgrade | Jefferies | Buy → Hold |
| 2024-08-19 | Iniziato | MoffettNathanson | Neutral |
| 2024-08-02 | Reiterato | Maxim Group | Hold |
| 2024-08-02 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-07-29 | Reiterato | TD Cowen | Buy |
| 2024-07-24 | Reiterato | JP Morgan | Overweight |
| 2024-07-15 | Aggiornamento | Loop Capital | Hold → Buy |
| 2024-07-15 | Reiterato | Morgan Stanley | Overweight |
| 2024-07-11 | Reiterato | BofA Securities | Buy |
| 2024-07-10 | Reiterato | Needham | Buy |
| 2024-07-09 | Reiterato | Piper Sandler | Neutral |
| 2024-06-28 | Reiterato | Oppenheimer | Outperform |
| 2024-06-26 | Aggiornamento | Rosenblatt | Neutral → Buy |
| 2024-06-25 | Reiterato | Evercore ISI | Outperform |
| 2024-06-25 | Reiterato | Maxim Group | Hold |
| 2024-06-18 | Reiterato | JP Morgan | Overweight |
| 2024-06-11 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2024-05-03 | Aggiornamento | Itau BBA | Underperform → Market Perform |
| 2024-05-03 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-04-29 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-04-17 | Iniziato | Maxim Group | Hold |
| 2024-04-11 | Reiterato | JP Morgan | Overweight |
| 2024-03-28 | Downgrade | DZ Bank | Buy → Hold |
| 2024-02-02 | Reiterato | Barclays | Underweight |
| 2024-02-02 | Reiterato | Goldman | Buy |
| 2024-02-02 | Reiterato | JP Morgan | Overweight |
| 2024-02-02 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Reiterato | Piper Sandler | Neutral |
| 2024-01-29 | Reiterato | Robert W. Baird | Outperform |
| 2024-01-18 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-01-10 | Downgrade | Redburn Atlantic | Buy → Neutral |
| 2024-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-03 | Ripresa | DA Davidson | Neutral |
| 2024-01-02 | Downgrade | Barclays | Equal Weight → Underweight |
| 2023-12-22 | Reiterato | Needham | Buy |
| 2023-10-31 | Reiterato | Jefferies | Buy |
| 2023-10-16 | Reiterato | Morgan Stanley | Overweight |
| 2023-10-04 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-13 | Reiterato | BofA Securities | Neutral |
| 2023-09-13 | Reiterato | Goldman | Buy |
| 2023-09-13 | Reiterato | Wedbush | Outperform |
| 2023-08-04 | Reiterato | Barclays | Equal Weight |
| 2023-08-04 | Reiterato | Canaccord Genuity | Buy |
| 2023-08-04 | Reiterato | Jefferies | Buy |
| 2023-08-04 | Reiterato | Morgan Stanley | Overweight |
| 2023-08-04 | Reiterato | Oppenheimer | Outperform |
| 2023-08-04 | Reiterato | Raymond James | Outperform |
| 2023-08-04 | Downgrade | Rosenblatt | Buy → Neutral |
| 2023-08-04 | Reiterato | Wedbush | Outperform |
| 2023-08-01 | Reiterato | JP Morgan | Overweight |
| 2023-08-01 | Reiterato | Robert W. Baird | Outperform |
| 2023-08-01 | Reiterato | TD Cowen | Outperform |
| 2023-07-31 | Reiterato | Piper Sandler | Overweight |
| 2023-07-27 | Reiterato | Bernstein | Mkt Perform |
| 2023-07-24 | Reiterato | Deutsche Bank | Buy |
| 2023-07-19 | Reiterato | BofA Securities | Neutral |
| 2023-07-17 | Reiterato | Morgan Stanley | Overweight |
| 2023-07-11 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2023-06-30 | Iniziato | Citigroup | Buy |
| 2023-06-13 | Downgrade | UBS | Buy → Neutral |
| 2023-06-06 | Downgrade | DA Davidson | Buy → Neutral |
| 2023-05-05 | Reiterato | Atlantic Equities | Overweight |
| 2023-05-05 | Reiterato | BofA Securities | Neutral |
| 2023-05-05 | Reiterato | Canaccord Genuity | Buy |
| 2023-05-05 | Reiterato | DA Davidson | Buy |
| 2023-05-05 | Reiterato | Deutsche Bank | Buy |
| 2023-05-05 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Reiterato | Monness Crespi & Hardt | Buy |
| 2023-05-05 | Reiterato | Morgan Stanley | Overweight |
| 2023-05-05 | Reiterato | Needham | Buy |
| 2023-05-05 | Reiterato | Piper Sandler | Overweight |
| 2023-05-05 | Reiterato | Rosenblatt | Buy |
| 2023-05-01 | Reiterato | BofA Securities | Neutral |
| 2023-04-26 | Reiterato | Barclays | Equal Weight |
| 2023-04-26 | Reiterato | Deutsche Bank | Buy |
| 2023-04-19 | Reiterato | JP Morgan | Overweight |
| 2023-04-06 | Reiterato | BofA Securities | Neutral |
| 2023-03-06 | Iniziato | Goldman | Buy |
| 2023-03-03 | Reiterato | Morgan Stanley | Overweight |
| 2023-01-27 | Reiterato | BofA Securities | Neutral |
| 2023-01-23 | Reiterato | Deutsche Bank | Buy |
| 2023-01-18 | Reiterato | Canaccord Genuity | Buy |
| 2023-01-03 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2022-12-20 | Reiterato | JP Morgan | Overweight |
| 2022-12-12 | Reiterato | Oppenheimer | Outperform |
| 2022-10-28 | Reiterato | Barclays | Equal Weight |
| 2022-10-28 | Reiterato | Citigroup | Buy |
| 2022-10-28 | Reiterato | Credit Suisse | Outperform |
| 2022-10-28 | Reiterato | DA Davidson | Buy |
| 2022-10-28 | Reiterato | Deutsche Bank | Buy |
| 2022-10-28 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-10-28 | Reiterato | Robert W. Baird | Outperform |
| 2022-10-28 | Reiterato | Wedbush | Outperform |
| 2022-10-17 | Reiterato | Morgan Stanley | Overweight |
| 2022-10-13 | Reiterato | Credit Suisse | Outperform |
| 2022-10-11 | Reiterato | Barclays | Equal Weight |
| 2022-09-29 | Aggiornamento | Rosenblatt | Neutral → Buy |
| 2022-06-28 | Reiterato | Evercore ISI | Outperform |
| 2022-05-25 | Reiterato | Loop Capital | Buy |
| 2022-04-19 | Iniziato | Rosenblatt | Neutral |
| 2022-01-28 | Reiterato | Monness Crespi & Hardt | Buy |
| 2022-01-28 | Aggiornamento | New Street | Sell → Neutral |
| 2021-12-14 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-12-13 | Reiterato | JP Morgan | Overweight |
| 2021-12-07 | Reiterato | Morgan Stanley | Overweight |
| 2021-12-06 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2021-10-29 | Ripresa | Credit Suisse | Neutral |
| 2021-09-15 | Reiterato | Cowen | Outperform |
| 2021-09-01 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2021-08-19 | Reiterato | JP Morgan | Overweight |
| 2021-07-28 | Reiterato | Barclays | Equal Weight |
| 2021-07-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-07-28 | Reiterato | Deutsche Bank | Buy |
| 2021-07-28 | Reiterato | Loop Capital | Buy |
| 2021-07-28 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-07-28 | Reiterato | Morgan Stanley | Overweight |
| 2021-07-28 | Reiterato | Oppenheimer | Outperform |
| 2021-07-28 | Reiterato | Piper Sandler | Overweight |
| 2021-07-28 | Reiterato | Wells Fargo | Overweight |
| 2021-07-28 | Reiterato | Wolfe Research | Underperform |
| 2021-07-22 | Reiterato | Canaccord Genuity | Buy |
| 2021-07-20 | Reiterato | UBS | Buy |
| 2021-07-14 | Reiterato | JP Morgan | Overweight |
| 2021-07-06 | Reiterato | JP Morgan | Overweight |
| 2021-06-24 | Reiterato | Morgan Stanley | Overweight |
| 2021-05-28 | Downgrade | New Street | Neutral → Sell |
| 2021-04-29 | Aggiornamento | Goldman | Sell → Neutral |
| 2021-04-06 | Reiterato | Morgan Stanley | Overweight |
| 2021-03-31 | Aggiornamento | UBS | Neutral → Buy |
| 2021-01-28 | Reiterato | Canaccord Genuity | Buy |
| 2021-01-28 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-01-28 | Reiterato | Needham | Buy |
| 2021-01-25 | Reiterato | Wedbush | Outperform |
| 2021-01-22 | Reiterato | Cowen | Outperform |
| 2021-01-21 | Reiterato | Morgan Stanley | Overweight |
| 2021-01-05 | Reiterato | Canaccord Genuity | Buy |
| 2020-12-16 | Reiterato | Morgan Stanley | Overweight |
| 2020-12-09 | Reiterato | Wedbush | Outperform |
| 2020-11-30 | Aggiornamento | Loop Capital | Hold → Buy |
| 2020-10-26 | Ripresa | Atlantic Equities | Overweight |
| 2020-09-21 | Reiterato | Citigroup | Buy |
| 2020-09-17 | Reiterato | Jefferies | Buy |
| 2020-09-16 | Reiterato | Needham | Buy |
| 2020-09-14 | Reiterato | Oppenheimer | Outperform |
| 2020-09-01 | Reiterato | Cowen | Outperform |
| 2020-09-01 | Reiterato | JP Morgan | Overweight |
| 2020-08-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2020-08-26 | Reiterato | Wedbush | Outperform |
| 2020-08-25 | Reiterato | Cowen | Outperform |
| 2020-08-24 | Reiterato | Morgan Stanley | Overweight |
| 2020-08-10 | Reiterato | Wedbush | Outperform |
| 2020-08-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-07-31 | Reiterato | Oppenheimer | Outperform |
| 2020-07-31 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-07-31 | Reiterato | UBS | Buy |
| 2020-07-31 | Reiterato | Wedbush | Outperform |
Mostra tutto
Apple Inc Borsa (AAPL) Ultime notizie
Assessing the Impact of Apple’s Insider Stock Sale on Investor Sentiment and Valuation - AInvest
Apple: Sell While AheadWeak AI And Mature Markets Signal Caution (NASDAQ:AAPL) - Seeking Alpha
Goldman Sachs issues high-stakes Apple stock forecast - TheStreet
Burlington tech firm takes on Apple in court over alleged patent violations - The Business Journals
Pixalate Research Finds 253 EU & UK-Registered Mobile Apps Likely Violating GDPR-K & UK Children's Code: Apple App Store & Google Play Store Apps Endangering Privacy Rights of 104M+ Children Across Europe - GlobeNewswire Inc.
What's being unveiled at the September 2025 Apple event? What we know - USA Today
Apple Stock Slips as Huawei Drops Trifold Phone Ahead of iPhone 17 - sg.finance.yahoo.com
Apple Leverages Google Antitrust Ruling for AI Gatekeeping Strategy - WebProNews
The Cowboys Have Surged 9,000% in Value Since 1989 to $12.8B, But That's Just a Fraction of The Return From Apple, Microsoft - Investopedia
The Zacks Analyst Blog Highlights Apple, Novartis, Charles Schwab, Community Bancorp and Optex Systems - Yahoo Finance
Meta, Apple woo Trump with $600B at White House dinner in China AI powerplay - Cryptopolitan
The Zacks Analyst Blog Highlights Apple, Amazon, Microsoft and Alphabet - TradingView
Apple Inc. (AAPL): China’s The “Wildcard,” Says Jim Cramer - Yahoo Finance
Apple Stock: Regulatory Clarity and Strategic Flexibility Make It a Buy in 2025 - AInvest
Apple upgraded, AMD downgraded: Wall Street’s top analyst calls - Yahoo Finance
Apple Stock: It's Still A Solid Buy Following Court Ruling (NASDAQ:AAPL) - Seeking Alpha
Donald Trump asks Tim Cook, Mark Zuckerberg, about their investment plan, here's what they said - DNA India
Ross Gerber Slams Warren Buffett's Apple Exit, Rejects… - inkl
Cerence Sues Apple Over Six Patents in Siri Voice Tech Dispute - WebProNews
Apple's Regulatory and Ethical Challenges: A Growing Risk for Long-Term Investors? - AInvest
Bose Looks to Fend Off Sony and Apple with Latest Headphones - Bloomberg.com
One Of Apple’s Most Scrutinized Services Could Soon Silence Critics (NASDAQ:AAPL) - Seeking Alpha
Ahead of iPhone 17 launch, Apple India smashes records with $9 billion in sales amid high demand - financialexpress.com
Have Apple Insiders Been Selling Stock? - simplywall.st
Everything Apple Plans to Show at Sept. 9 ‘Awe Dropping’ iPhone 17 Event - Bloomberg.com
Apple’s India Strategy: A Strategic Pivot for Long-Term Growth in a Shifting Global Landscape - AInvest
Tesla's Apple App Store Rank Race With Uber, Waymo Isn't Bullish, Says Gary Black As TSLA Stock Still Trails Nasdaq - Benzinga
Meta's Mark Zuckerberg & Apple's Tim Cook pledge to invest ‘$600 billion’ in US at Trump’s White House dinner - Mint
Apple’s India push: Building loyalty, one local touch at a time - AInvest
Tesla Robotaxi Downloads Outpace Uber By 40% On Apple's App Store Amid Ease Of Self-Driving Regulations - Benzinga
Cerence AI Files Patent Infringement Suit Against Apple - AiThority
Apple’s India sales hit record US$9 billion after big retail push - The Business Times
Apple sales in India climb to $9 billion as local production expands - CryptoRank
Apple Pay vs Alipayhk: Compare on Fees, Features & Benefits - OneSafe
Apple Pay vs Chime: Compare on Fees, Features & Benefits - OneSafe
Apple Pay vs Mobilepay: Compare on Fees, Features & Benefits - OneSafe
Apple (AAPL) Hits $9B in India Sales — Is This Just the Beginning? - TipRanks
Apple’s India Sales Hit Record $9 Billion After Big Retail Push - Yahoo Finance
Apple Revives Blood Oxygen Monitoring in US After Legal Standoff with Masimo - AInvest
Apple iPhone 17 series may launch at a starting price of Rs 86,000: Report - Business Standard
Apple’s India Sales Hit Record $9B As iPhone Demand Surges: 2 New Stores Open - Stocktwits
Trump: Substantial semiconductor tariff coming 'very shortly', Apple could be exempt - ca.finance.yahoo.com
1 in 5 iPhones Now Made In India, Apple Sales Hit $9 Billion After Retail Push - Times Now
Apple Pay vs N26: Compare on Fees, Features & Benefits - OneSafe
Apple Pay vs Mbway: Compare on Fees, Features & Benefits - OneSafe
Apple Pay vs Flutterwave: Compare on Fees, Features & Benefits - OneSafe
Apple Pay vs Coinpayments: Compare on Fees, Features & Benefits - OneSafe
Apple Pay vs C24: Compare on Fees, Features & Benefits - OneSafe
How Apple’s India Sales Soar to Record $9 BillionAggressive Retail Push, Student Discounts & More - Times Now
Apple's AI Story Could Finally Take Off, Says Gene… - inkl
Apple's India sales hit record $9 billion on high demand, big retail push - Business Standard
Apple Inc Azioni (AAPL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.13%
1.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):